Clinical Trial Update: Immune Modulation by Parenteral Fish Oil in Patients With Crohn's Disease [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated immune modulation by parenteral fish oil in Crohn's disease and the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Parenteral Fish Oil (fish oil)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Crohn Disease | Phase 4 | Status: COMPLETED